Works matching IS 02724391 AND DT 2021 AND VI 82 AND IP 3

Results: 15

TWIRLS, a knowledge‐mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2.

Published in:: Drug Development Research, 2021, v. 82, n. 3, p. 465, doi. 10.1002/ddr.21817
Publication type:: Article

Calcium sensing receptor as a novel target for treatment of sepsis induced cardio‐renal syndrome: Need for exploring mechanisms.

Published in:

Drug Development Research, 2021, v. 82, n. 3, p. 305, doi. 10.1002/ddr.21797

By:

Yadav, Shubham;
Gupta, Kirti;
Deshmukh, Khalid;
Bhardwaj, Loveinder;
Dahiya, Ashish;
Krishan, Pawan;
Singh, Gaaminepreet

Publication type:

Article

N‐(3′,4′‐dimethoxycinnamonyl) anthranilic acid alleviates severe acute pancreatitis by inhibiting intestinal barrier dysfunction and NF‐κB activation.

Published in:

Drug Development Research, 2021, v. 82, n. 3, p. 458, doi. 10.1002/ddr.21769

By:

Zhao, Zhicheng;
Lu, Li;
Li, Weidong

Publication type:

Article

Design of multicomponent indomethacin‐paracetamol and famotidine loaded nanoparticles for sustained and effective anti‐inflammatory therapy.

Published in:

Drug Development Research, 2021, v. 82, n. 3, p. 448, doi. 10.1002/ddr.21768

By:

Assali, Mohyeddin;
Zohud, Nihal

Publication type:

Article

Synergistic interaction between B vitamins and statins to counter nociception in rats.

Published in:

Drug Development Research, 2021, v. 82, n. 3, p. 440, doi. 10.1002/ddr.21767

By:

Skiold, López‐Canales Jorge;
Estefania, Ruiz‐Pedraza Paola;
Carolina, García‐Paz María Paola;
Mery, López‐Mayorga Ruth;
Fernando, Castillo‐Henkel Enrique;
Jair, Lozano‐Cuenca

Publication type:

Article

Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma.

Published in:

Drug Development Research, 2021, v. 82, n. 3, p. 430, doi. 10.1002/ddr.21766

By:

Zhang, Fan;
Duan, Jingjing;
Song, Hailin;
Yang, Li;
Zhou, Ming;
Wang, Xuewen

Publication type:

Article

Proteolysis targeting chimera (PROTAC) for epidermal growth factor receptor enhances anti‐tumor immunity in non‐small cell lung cancer.

Published in:

Drug Development Research, 2021, v. 82, n. 3, p. 422, doi. 10.1002/ddr.21765

By:

Wang, Kai;
Zhou, Hongping

Publication type:

Article

Fenofibrate attenuates ischemia reperfusion‐induced acute kidney injury and associated liver dysfunction in rats.

Published in:

Drug Development Research, 2021, v. 82, n. 3, p. 412, doi. 10.1002/ddr.21764

By:

Kaur, Jashanpreet;
Kaur, Tajpreet;
Sharma, Ashwani Kumar;
Kaur, Japneet;
Yadav, Harlokesh Narayan;
Pathak, Devendra;
Singh, Amrit Pal

Publication type:

Article

Paeoniflorin inhibited nod‐like receptor protein‐3 inflammasome and NF‐κB‐mediated inflammatory reactions in diabetic foot ulcer by inhibiting the chemokine receptor CXCR2.

Published in:

Drug Development Research, 2021, v. 82, n. 3, p. 404, doi. 10.1002/ddr.21763

By:

Sun, Xiaolong;
Wang, Xu;
Zhao, Zhenyu;
Chen, Jing;
Li, Cheng;
Zhao, Gang

Publication type:

Article

Barbiturate derivatives for managing multifaceted oncogenic pathways: A mini review.

Published in:

Drug Development Research, 2021, v. 82, n. 3, p. 364, doi. 10.1002/ddr.21761

By:

Prasher, Parteek;
Sharma, Mousmee;
Singh, Samarth P.;
Rawat, Devendra S.

Publication type:

Article

Role of mineralocorticoid receptor antagonists in kidney diseases.

Published in:

Drug Development Research, 2021, v. 82, n. 3, p. 341, doi. 10.1002/ddr.21760

By:

Patel, Vishal;
Joharapurkar, Amit;
Jain, Mukul

Publication type:

Article

Ameliorative effect of a nano chromium metal–organic framework on experimental diabetic chronic kidney disease.

Published in:

Drug Development Research, 2021, v. 82, n. 3, p. 393, doi. 10.1002/ddr.21759

By:

Fakharzadeh, Saideh;
Kalanaky, Somayeh;
Argani, Hassan;
Dadashzadeh, Simin;
Torbati, Peyman Mohammadi;
Nazaran, Mohammad Hassan;
Basiri, Abbas

Publication type:

Article

Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review.

Published in:

Drug Development Research, 2021, v. 82, n. 3, p. 309, doi. 10.1002/ddr.21758

By:

Kunjiappan, Selvaraj;
Pavadai, Parasuraman;
Vellaichamy, Sivakumar;
Ram Kumar Pandian, Sureshbabu;
Ravishankar, Vigneshwaran;
Palanisamy, Ponnusamy;
Govindaraj, Saravanan;
Srinivasan, Gowshiki;
Premanand, Adhvitha;
Sankaranarayanan, Murugesan;
Theivendren, Panneerselvam

Publication type:

Article

Step toward repurposing drug discovery for COVID‐19 therapeutics through in silico approach.

Published in:

Drug Development Research, 2021, v. 82, n. 3, p. 374, doi. 10.1002/ddr.21757

By:

Marak, Brilliant N.;
Dowarah, Jayanta;
Khiangte, Laldingluaia;
Singh, Ved Prakash

Publication type:

Article

Issue Information.

Published in:: Drug Development Research, 2021, v. 82, n. 3, p. 303, doi. 10.1002/ddr.21692
Publication type:: Article